Recommended INN: List 84.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 687
- Publication type:
- Article
Works matching IS 10109609 AND DT 2020 AND VI 34 AND IP 3
Results: 17
1
2
WHO Biowaiver Study Project for COVID-19 Outbreak: Dexamethasone Solubility Results for Biopharmaceutical Classification System.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 466
- Publication type:
- Article
3
WHO External Quality Assurance Assessment Scheme Phase 9.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 453
- Publication type:
- Article
4
WHO Biowaiver Study Project for COVID-19 Outbreak: Dexamethasone Solubility Results for Biopharmaceutical Classification System.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 466
- Publication type:
- Article
5
Good reliance practices in regulatory decision-making for medical products: high-level principles and considerations.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 606
- Publication type:
- Article
6
ALBENDAZOLE CHEWABLE TABLETS (ALBENDAZOLI COMPRESSI MANDUCABILI).
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 600
- Publication type:
- Article
7
3.6 TEST FOR HISTAMINE-LIKE SUBSTANCES (VASODEPRESSOR SUBSTANCES).
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 597
- Publication type:
- Article
8
Good regulatory practices for regulatory oversight of medical products.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 559
- Publication type:
- Article
9
POLICY: EVALUATING AND PUBLICLY DESIGNATING REGULATORY AUTHORITIES AS WHO LISTED AUTHORITIES.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 548
- Publication type:
- Article
10
REVISION OF CHAPTER 2.1: GENERAL IDENTIFICATION TESTS.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 540
- Publication type:
- Article
11
GOOD MANUFACTURING PRACTICES: WATER FOR PHARMACEUTICAL USE.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 516
- Publication type:
- Article
12
POWDERS FOR INHALATION (INHALANDA).
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 509
- Publication type:
- Article
13
ZANAMIVIR POWDER FOR INHALATION, PRE-METERED (ZANAMIVIRI PULVIS PRO INHALATIONE).
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 502
- Publication type:
- Article
14
ZANAMIVIR (ZANAMIVIRUM).
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 492
- Publication type:
- Article
15
WHO Biowaiver Project - Preparation for cycle IV (2021): Prioritization exercise of active pharmaceutical ingredients on the WHO Model List of Essential Medicines for solubility determination and Biopharmaceutics Classification System-based classification.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 485
- Publication type:
- Article
16
DISSOLUTION TEST FOR SOLID ORAL DOSAGE FORMS: Draft proposal for revision in The International Pharmacopoeia.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 472
- Publication type:
- Article
17
Proposed INN: List 124 -- COVID-19 (special edition).
- Published in:
- WHO Drug Information, 2020, v. 34, n. 3, p. 641
- Publication type:
- Article